About Technology Issues FAQ

Links

Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma

Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.